• FirefoxUpgrade to the new Firefox »
  •  Dow Down 1.55% Nasdaq Down 1.75%

    Sunesis Pharmaceuticals, Inc. (SNSS)

    -NasdaqCM
    2.41 Up 0.05(2.12%) 10:02AM EST - Nasdaq Real Time Price
    Add to Portfolio
    Prev Close:2.36
    Open:2.32
    Bid:2.36 x 1000
    Ask:2.37 x 800
    1y Target Est:3.38
    Beta:3.02
    Earnings Date:Mar 4 - Mar 9 (Est.)
    Day's Range:2.31 - 2.41
    52wk Range:1.00 - 8.46
    Volume:128,851
    Avg Vol (3m):1,837,940
    Market Cap:149.30M
    P/E (ttm):N/A
    EPS (ttm):-0.85
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for SNSS

    Comparison

    Symbol% ChgMkt Cap
    SNSSUp 2.12%149.30M
    AZNUp 1.26%90.25B
    PFEUp 1.55%209.87B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):21.41
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-14) :-0.86
    Quarterly EPS Est (Dec-14) :-0.20
    Mean Recommendation*:2.5
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Sunesis Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of oncology therapeutics for the treatment of solid and hematologic cancers. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback